Literature DB >> 20920769

The epidemiology of ocular and nasal allergy in the United States, 1988-1994.

Kavita Singh1, Sara Axelrod, Leonard Bielory.   

Abstract

BACKGROUND: Allergies give rise to the fifth-leading group of chronic diseases. However, the specific prevalence of ocular allergy is poorly described.
OBJECTIVE: We sought to provide a more accurate representation of the epidemiology of ocular allergy in the United States.
METHODS: The National Health And Nutrition Examination Survey III performed in the United States from 1988-1994 was the source for the data collected. Items from the questionnaire regarding ocular and nasal allergy symptoms in relation to skin prick testing were stratified by age, race, region, and sex.
RESULTS: The sample size is 20,010: 1,285 (6.4%) reported ocular symptoms, 3,294 (16.5%) reported nasal symptoms, 5,944 (29.7%) reported both ocular and nasal symptoms, and 9.487 (47.4%) were asymptomatic. Forty percent of the population reported at least 1 occurrence of ocular symptoms in the past 12 months. Those 50 years and older have a higher frequency of isolated ocular symptoms (P < .001). There is an increase in the frequency of symptoms in those younger than 50 years in the populations of subjects with ocular and nasal symptoms combined and isolated nasal symptoms (P < .001). Ocular symptoms are more frequent than nasal symptoms in relation to animals (P < .001), household dust (P < .001), and pollen (P < .001).
CONCLUSION: This analysis provides the first representation of the epidemiology of ocular allergy in the United States. Up to 40% of the population, the highest reported to date, have experienced ocular symptoms at least once in their lifetime, with a peak of symptoms in the months of June and July.
Copyright © 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20920769     DOI: 10.1016/j.jaci.2010.06.050

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  41 in total

1.  Determination of seasonal allergic conjunctivitis variation using internet search engine data.

Authors:  R Imonikhe; T H Flynn; A A Mearza
Journal:  Eye (Lond)       Date:  2011-10-14       Impact factor: 3.775

Review 2.  Recent patents and emerging therapeutics in the treatment of allergic conjunctivitis.

Authors:  Gyan P Mishra; Viral Tamboli; Jwala Jwala; Ashim K Mitra
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2011-01

3.  TGFβ receptor mutations impose a strong predisposition for human allergic disease.

Authors:  Pamela A Frischmeyer-Guerrerio; Anthony L Guerrerio; Gretchen Oswald; Kristin Chichester; Loretha Myers; Marc K Halushka; Maria Oliva-Hemker; Robert A Wood; Harry C Dietz
Journal:  Sci Transl Med       Date:  2013-07-24       Impact factor: 17.956

Review 4.  Atopy and Specific Cancer Sites: a Review of Epidemiological Studies.

Authors:  Yubao Cui; Andrew W Hill
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

Review 5.  Emerging Therapeutics for Ocular Surface Disease.

Authors:  Leonard Bielory; Dovid Schoenberg
Journal:  Curr Allergy Asthma Rep       Date:  2019-02-28       Impact factor: 4.806

6.  Allergic sensitization and clinical outcomes in urban children with asthma, 2013-2016.

Authors:  Sairaman Nagarajan; Sabina Ahmad; Markus Quinn; Sabhyata Agrawal; Elena Manilich; Emily Concepcion; Haesoon Lee
Journal:  Allergy Asthma Proc       Date:  2018-07-01       Impact factor: 2.587

7.  The association between asthma and allergic disease and mortality: a 30-year follow-up study.

Authors:  Jessica H Savage; Elizabeth C Matsui; Meredith McCormack; Augusto A Litonjua; Robert A Wood; Corinne A Keet
Journal:  J Allergy Clin Immunol       Date:  2014-03-14       Impact factor: 10.793

8.  Surveillance Tools Emerging From Search Engines and Social Media Data for Determining Eye Disease Patterns.

Authors:  Michael S Deiner; Thomas M Lietman; Stephen D McLeod; James Chodosh; Travis C Porco
Journal:  JAMA Ophthalmol       Date:  2016-09-01       Impact factor: 7.389

9.  Atopic Keratoconjunctivitis: Pharmacotherapy for the Elderly.

Authors:  Erminia Ridolo; P Kihlgren; I Pellicelli; M C Nizi; F Pucciarini; C Incorvaia
Journal:  Drugs Aging       Date:  2019-07       Impact factor: 3.923

10.  Bayesian Analysis of Climate Change Effects on Observed and Projected Airborne Levels of Birch Pollen.

Authors:  Yong Zhang; Sastry Isukapalli; Leonard Bielory; Panos Georgopoulos
Journal:  Atmos Environ (1994)       Date:  2012-11-12       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.